Obesity Scheme Leader Received Payments from GLP-1 Drug Companies | Retatrutide News

A leader of a national obesity treatment scheme received nearly £80,000 from GLP-1 drug firms. This raises concerns about potential conflicts of interes...
Market News · October 28, 2026